Last checked at 23 Jul 2009 16:17
| For Immediate Release | 23 July 2009 |
ImmuPharma PLC
Directors' Dealings
Institutions increase stake
ImmuPharma PLC ('ImmuPharma' or the 'Company') (LSE:IMM) announces that a number of existing and new blue-chip institutional investors have purchased shares from Richard Warr and the Trusts of Richard Warr and Dimitri Dimitriou, who are two of ImmuPharma's founders and Directors. A total of 12.5 million ordinary shares (16.1% of the issued share capital) of 10 pence each in the Company, were placed by Noble & Company Limited at a price of 86 pence per share to institutional investors on 23 July 2009. Panmure Gordon is the NOMAD and Corporate Broker to the Company.
Following the disposal, the current holdings directly or through Trust are:
| Ordinary Shares Sold | Ordinary Shares Retained | Percentage of shares in issue | |
| Richard Warr (1) | 6,250,000 | 3,528,968 | 4.6% |
| Dimitri Dimitriou (2) | 6,250,000 | 3,528,969 | 4.6% |
| Dr Zimmer & Family | 0 | 23,056,602 | 29.8% |
(1) Ordinary shares of £0.10 held by Louvre Trustees Limited where the Warr family has a beneficial interest and shares held directly by Richard Warr.
(2) Ordinary shares of £0.10 held by Louvre Trustees Limited where the Dimitriou family has a beneficial interest.
Richard Warr, ImmuPharma's Chairman said: "We are delighted with the support received from our existing investors and the demand from new investors including M&G Investments. The allocation of these shares further increases ImmuPharma's free float with the aim of improving overall liquidity."
For further information please contact:
| ImmuPharma PLC | +44 20 7152 4080 |
| Dimitri Dimitriou, Chief Executive Officer | |
| Richard Warr, Chairman | |
| Panmure Gordon | +44 151 243 0963 |
| Andrew Burnett/ Rakesh Sharma | |
| Noble & Company Limited | +44 20 7763 2335 |
| John Millar | |
| Buchanan Communications | +44 20 7466 5000 |
| Lisa Baderoon | |
| Rebecca Skye Dietrich |
More information on the Company can be found at www.immupharma.com